50 employees
Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain.
2010
$4M
from 1 investors over 1 rounds
Alcyone Lifesciences, Inc. raised $4M on January 15, 2014
Investors: Harbor Light Captial Partners